Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Feb 2022 for Fluidigm CORP. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Colin McCracken: trading record in brief
All filings by Colin McCracken on record concern Standard Biotools Inc., in the capacity of senior executive. Between 20 May 2021 and 22 February 2022, the trades on record add up to 4 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 24 February 2022 came the latest disclosure, an option exercise in Standard Biotools Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Colin McCracken
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
1,531 shares0Common StockSEC:0001162194-22-000017:0
2,598 shares0Common StockSEC:0001162194-21-000097:0
2,597 shares0Common StockSEC:0001162194-21-000082:0
2,598 shares0Common StockSEC:0001162194-21-000042:0
4 of 4 declarations
